Hongchuan Jin Selected Research

Hongchuan Jin Research Topics

Disease

80	Neoplasms (Cancer) 11/2023 - 02/2004
23	Stomach Neoplasms (Stomach Cancer) 01/2022 - 02/2009
16	Breast Neoplasms (Breast Cancer) 11/2023 - 01/2012
11	Carcinogenesis 01/2021 - 07/2007
10	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 08/2008
5	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 09/2009
4	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2021
3	Liver Neoplasms (Liver Cancer) 06/2023 - 01/2022
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2011
3	Carcinoma (Carcinomatosis) 02/2011 - 08/2010
2	Colitis 01/2023 - 01/2018
2	Leukemia 01/2022 - 06/2017
2	Gastritis 01/2021 - 01/2019
2	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2011
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2019 - 08/2006
2	Starvation 07/2017 - 06/2017
2	Colonic Neoplasms (Colon Cancer) 06/2017 - 03/2010
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2014 - 09/2009
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2004
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2007
10	MicroRNAs (MicroRNA)IBA 05/2023 - 09/2009
6	Messenger RNA (mRNA)IBA 01/2023 - 03/2010
6	Glutamine (L-Glutamine)FDA Link 06/2022 - 06/2017
5	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 06/2022 - 04/2016
4	6-methyladenineIBA 01/2023 - 01/2018
4	EnzymesIBA 01/2022 - 07/2012
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2013
4	Long Noncoding RNAIBA 01/2022 - 01/2019
4	Sirtuin 1IBA 01/2021 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 02/2012
3	CytokinesIBA 01/2023 - 05/2016
3	HydrolasesIBA 01/2022 - 08/2008
3	pevonedistatIBA 01/2022 - 04/2016
3	Neurofibromin 2 (Merlin)IBA 01/2021 - 08/2006
3	Lysine (L-Lysine)FDA Link 01/2021 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 10/2010
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 01/2011
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2011
2	Estrogen ReceptorsIBA 01/2023 - 01/2014
2	Decitabine FDA Link 01/2023 - 01/2011
2	TubulinIBA 01/2023 - 02/2021
2	hydrogen sulfite (bisulfite)IBA 01/2021 - 01/2013
2	PhosphoproteinsIBA 01/2021 - 01/2016
2	ras GTPase-Activating Proteins (ras-GAP)IBA 01/2021 - 07/2007
2	AcidsIBA 11/2020 - 05/2013
2	Immune Checkpoint InhibitorsIBA 11/2020 - 01/2020
2	CateninsIBA 01/2020 - 06/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2019 - 01/2014
2	Hormones (Hormone)IBA 01/2019 - 01/2017
2	Gefitinib (Iressa)FDA Link 01/2019 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2012
2	RNA (Ribonucleic Acid)IBA 01/2018 - 11/2016
2	Histones (Histone)IBA 01/2017 - 01/2013
2	Tamoxifen FDA LinkGeneric 01/2017 - 01/2016
2	theasinensin AIBA 01/2015 - 01/2013
2	trichostatin A (A 300)IBA 01/2015 - 01/2013
2	histone deacetylase 3IBA 01/2015 - 01/2013
2	Mitogen-Activated Protein KinasesIBA 09/2014 - 07/2012
2	Histone Deacetylase InhibitorsIBA 01/2014 - 01/2013
2	elemeneIBA 01/2014 - 12/2012
2	CaspasesIBA 01/2014 - 12/2012
2	Caspase 9IBA 12/2012 - 07/2012
2	Peptides (Polypeptides)IBA 09/2012 - 08/2010
2	Caspase 8 (Caspase-8)IBA 07/2012 - 02/2009
2	AntigensIBA 05/2011 - 08/2010
2	UbiquitinIBA 06/2010 - 08/2008
2	beta CateninIBA 09/2009 - 07/2007
2	SuperantigensIBA 05/2004 - 02/2004
1	erastinIBA 06/2023
1	CopperIBA 06/2023
1	Sorafenib (BAY 43-9006)FDA Link 06/2023
1	IonophoresIBA 06/2023
1	Proteasome InhibitorsIBA 01/2023
1	130-nm albumin-bound paclitaxelIBA 01/2023
1	eribulin FDA Link 01/2023
1	Serotonin ReceptorsIBA 01/2023
1	VimentinIBA 01/2023
1	Clomipramine (Anafranil)FDA LinkGeneric 01/2023
1	Guanosine Triphosphate (GTP)IBA 01/2022
1	GuanosineIBA 01/2022
1	Guanine NucleotidesIBA 01/2022
1	Drug CombinationsIBA 01/2022
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2022
1	CrizotinibIBA 01/2022
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2022
1	triphosphoric acid (triphosphate)IBA 01/2022
1	nelarabine (506U78)FDA Link 01/2022
1	SAM Domain and HD Domain-Containing Protein 1IBA 01/2022
1	coumarinIBA 12/2021
1	Bortezomib (Velcade)FDA Link 10/2021
1	Activating Transcription Factor 4IBA 10/2021
1	ABT751IBA 02/2021

Therapy/Procedure

27	Therapeutics 01/2022 - 02/2004
12	Drug Therapy (Chemotherapy) 01/2022 - 01/2013
5	Radiotherapy 02/2022 - 01/2014
4	Immunotherapy 11/2020 - 05/2004
1	Cell Transplantation 01/2023